Long-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study

Clinical Nutrition

Volumn 34, Issue 5, 2015, Pages 911-917

  De Giorgi, Sara ^a   Campos, Vanessa ^a   Egli, Leonie ^a   Toepel, Ulrike ^b   Carrel, Guillaume ^a   Cariou, Bertrand ^c   Rainteau, Dominique ^d   Schneiter, Philippe ^a   Tappy, Luc ^a   Giusti, Vittorio ^e  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c L INSTITUT DU THORAX   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e Center for Metabolic Diseases   (Switzerland)

Author keywords

Apoprotein B48; Bariatric surgery; Bile acids; Fibroblast growth factor 19; Gut hormones; Triglyceride rich lipoproteins

Indexed keywords

APOLIPOPROTEIN B48; BILE ACID; CHOLECYSTOKININ; FATTY ACID; FIBROBLAST GROWTH FACTOR 19; GLUCAGON LIKE PEPTIDE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; APOLIPOPROTEIN B; FGF19 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BILE ACID SYNTHESIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; LIPID ABSORPTION; LIPID BLOOD LEVEL; OBESITY; PILOT STUDY; PROTEIN BLOOD LEVEL; ROUX Y ANASTOMOSIS; BLOOD; BODY MASS; GLUCOSE BLOOD LEVEL; MEAL; METABOLISM; POSTPRANDIAL STATE; STOMACH BYPASS; TIME FACTOR;

ADULT; APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; BILE ACIDS AND SALTS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLECYSTOKININ; CROSS-SECTIONAL STUDIES; FEMALE; FIBROBLAST GROWTH FACTORS; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; MEALS; OBESITY; PILOT PROJECTS; POSTPRANDIAL PERIOD; TIME FACTORS; TRIGLYCERIDES;

EID: 84939260764     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.09.018     Document Type: Article

References (30)

1. Buchwald H., Oien D.M. Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013, 23:427-436.
2. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W., Fahrbach K., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004, 292:1724-1737.
3. Schauer P.R., Bhatt D.L., Kirwan J.P., Wolski K., Brethauer S.A., Navaneethan S.D., et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014, 370:2002-2013.
4. Lubrano C., Cornoldi A., Pili M., Falcone S., Brandetti F., Fabbrini E., et al. Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years' follow-up. Int J Obes Relat metabolic Disord J Int Assoc Study Obes 2004, 28:1600-1606.
5. Brolin R.E., Bradley L.J., Wilson A.C., Cody R.P. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg 2000, 4:464-469.
6. Laferrere B. Gut feelings about diabetes. Endocrinol Nutr 2012, 59:254-260.
7. Pournaras D.J., Glicksman C., Vincent R.P., Kuganolipava S., Alaghband-Zadeh J., Mahon D., et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012, 153:3613-3619.
8. Galman C., Arvidsson I., Angelin B., Rudling M. Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood. J Lipid Res 2003, 44:859-866.
9. Cicione C., Degirolamo C., Moschetta A. Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver. Hepatology 2012, 56:2404-2411.
10. Suter M., Giusti V., Heraief E., Zysset F., Calmes J.M. Laparoscopic Roux-en-Y gastric bypass: initial 2-year experience. Surg Endosc 2003, 17:603-609.
11. Humbert L., Maubert M.A., Wolf C., Duboc H., Mahe M., Farabos D., et al. Bile acid profiling in human biological samples: comparison of extraction procedures and application to normal and cholestatic patients. J Chromatogr B Anal Technol Biomed Life Sci 2012, 899:135-145.
12. Steiner C., von Eckardstein A., Rentsch K.M. Quantification of the 15 major human bile acids and their precursor 7alpha-hydroxy-4-cholesten-3-one in serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 2010, 878:2870-2880.
13. Zlabek J.A., Grimm M.S., Larson C.J., Mathiason M.A., Lambert P.J., Kothari S.N. The effect of laparoscopic gastric bypass surgery on dyslipidemia in severely obese patients. Surg Obes Relat Dis 2005, 1:537-542.
14. Nguyen N.T., Varela E., Sabio A., Tran C.L., Stamos M., Wilson S.E. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg 2006, 203:24-29.
15. Ricci C., Gaeta M., Rausa E., Macchitella Y., Bonavina L. Early impact of bariatric surgery on type II diabetes, hypertension, and hyperlipidemia: a systematic review, meta-analysis and meta-regression on 6,587 patients. Obes Surg 2014, 24:522-528.
16. Rodieux F., Giusti V., D'Alessio D.A., Suter M., Tappy L. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity 2008, 16:298-305.
17. Keating N., Keely S.J. Bile acids in regulation of intestinal physiology. Curr Gastroenterol Rep 2009, 11:375-382.
18. Goldberg I.J., Eckel R.H., Abumrad N.A. Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways. J Lipid Res 2009, 50(Suppl.):S86-S90.
19. Kim S.Y., Park S.M., Lee S.T. Apolipoprotein C-II is a novel substrate for matrix metalloproteinases. Biochem Biophys Res Commun 2006, 339:47-54.
20. Kast H.R., Nguyen C.M., Sinal C.J., Jones S.A., Laffitte B.A., Reue K., et al. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. Mol Endocrinol 2001, 15:1720-1728.
21. Nakatani H., Kasama K., Oshiro T., Watanabe M., Hirose H., Itoh H. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism: Clin Exp 2009, 58:1400-1407.
22. Steinert R.E., Peterli R., Keller S., Meyer-Gerspach A.C., Drewe J., Peters T., et al. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity (Silver Spring) 2013, 21:E660-E668.
23. Lefebvre P., Cariou B., Lien F., Kuipers F., Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009, 89:147-191.
24. Thomas C., Gioiello A., Noriega L., Strehle A., Oury J., Rizzo G., et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009, 10:167-177.
25. Fu L., John L.M., Adams S.H., Yu X.X., Tomlinson E., Renz M., et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 2004, 145:2594-2603.
26. Haeusler R.A., Astiarraga B., Camastra S., Accili D., Ferrannini E. Human insulin resistance is associated with increased plasma levels of 12alpha-hydroxylated bile acids. Diabetes 2013, 62:4184-4191.
27. Cariou B., Chetiveaux M., Zair Y., Pouteau E., Disse E., Guyomarc'h-Delasalle B., et al. Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults. Nutr Metab (Lond) 2011, 8:48.
28. Simonen M., Dali-Youcef N., Kaminska D., Venesmaa S., Kakela P., Paakkonen M., et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg 2012, 22:1473-1480.
29. Werling M., Vincent R.P., Cross G.F., Marschall H.U., Fandriks L., Lonroth H., et al. Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery. Scand J Gastroenterol 2013, 48:1257-1264.
30. Ahmad N.N., Pfalzer A., Kaplan L.M. Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes (Lond) 2013, 37:1553-1559.